Fate Therapeutics, Inc. (FATE)
1.57
+0.09
(+6.08%)
USD |
NASDAQ |
Feb 26, 15:27
Fate Therapeutics Free Cash Flow : -115.43M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| MannKind Corp. | 42.74M |
| Vertex Pharmaceuticals, Inc. | 3.194B |
| Ardelyx, Inc. | -43.98M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -24.37M |
| Cash from Investing (Quarterly) | 21.27M |
| Cash from Financing (Quarterly) | 2.475M |
| Free Cash Flow Per Share (Quarterly) | -0.2233 |
| Free Cash Flow to Equity (Quarterly) | -24.49M |
| Free Cash Flow to Firm (Quarterly) | -26.58M |
| Free Cash Flow Yield | -62.08% |